SCHEMBL4741224

SCHEMBL4741224

COc1ccc(-c2nc(N)nc3c2-c2cc(N)c(Cl)cc2CC3)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 3/20 0.53
HRH2 P25021 2/20 0.53
PDCD1 Q15116 1/20 0.44
CD274 Q9NZQ7 1/20 0.44
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 2/20 0.44
MAPT P10636 2/20 0.44
HTT P42858 2/20 0.44
TYMS P04818 2/20 0.42
ADORA1 P30542 3/20 0.42
KMT2A Q03164 1/20 0.42
ADORA2A P29274 2/20 0.41
DYRK1A Q13627 1/20 0.39
GAA P10253 1/20 0.38
EGFR P00533 1/20 0.38
HSP90AA1 P07900 2/20 0.38
HSP90AB1 P08238 2/20 0.38
POLB P06746 1/20 0.37
TP53 P04637 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4740434 0.88 ADORA2A (0.51) HRH3HRH2KDM4EALDH1A1MAPT
SCHEMBL4741268 0.86 TYMS (0.57) HRH3HRH2PDCD1CD274KDM4E
SCHEMBL4740440 0.85 TYMS (0.41) HRH3HRH2KDM4ETYMSADORA1
SCHEMBL4741246 0.84 TYMS (0.42) KDM4EALDH1A1TYMSADORA1ADORA2A
SCHEMBL4741259 0.83 TYMS (0.41) HRH3HRH2KDM4EALDH1A1TYMS
SCHEMBL4741116 0.82 DHFR (0.40) TYMSADORA1ADORA2A
SCHEMBL4740744 0.81 TYMS (0.40) KDM4EALDH1A1MAPTHTTTYMS
SCHEMBL4741122 0.79 TYMS (0.55) HRH3HRH2KDM4EALDH1A1MAPT
SCHEMBL4786839 0.77 PIKFYVE (0.39) TYMSADORA2A
SCHEMBL4741251 0.77 ADORA2A (0.43) KDM4EMAPTTYMSADORA1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008086158-A1 BENZODIHYDROQUINAZOLINE AS PI3 KINASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2008-07-17 WO disclosed